Patients in Australia will soon be in a position to control what health information medical workers will be allowed to access. The patient choice is part of a plan to create a national electronic medical records system. Under the new system, called
Patients in Australia will soon be in a position to control what health information medical workers will be allowed to access. The patient choice is part of a plan to create a national electronic medical records system.
Under the new system, called HealthConnect, patients would be able to block personal details, such as sexually transmitted diseases and mental health issues.
The National Electronic Health Records Taskforce proposed the system in December. It is intended to improve care by allowing healthcare workers to access patients' medical records instantly on a computer. Access to records is especially important when patients are unconscious or unable to communicate.
HealthConnect would allow personal health information to be collected at the point of care in a standard electronic format, securely stored, and transmitted - but only with the patient's permission.
With consent, these event summaries would then be retrieveable any time they were needed and exchanged via a secure network with healthcare providers authorized by patients to access the information.
The proposed network would define the boundaries around who has access to what information and when. Only authorized users who need to know a particular part of a health record would be allowed access to that information.
"The information recorded in the HealthConnect trials includes clinical diagnoses, treatments, pathology test results, and prescribed medications," said Greg Lee, acting manager of the HealthConnect Program Office in the Commonwealth Department of Health and Ageing.
No decision has been made yet concerning inclusion of medical images.
"This decision will be influenced by benefits, telecommunications capacity, and storage requirements," Lee said.
Backers of the plan believe having more complete and up-to-date information available would mean that patients and their providers would be in a better position to make decisions together.
"The system would promote better coordination of care, reduce unnecessary duplication of services, and create a comprehensive lifetime record for the patient," Lee said.
HealthConnect would also provide an opportunity to increase privacy protection compared with existing paper-based systems.
Currently, two HealthConnect trials are under way - one in the Katherine region of the Northern Territory and one in the Clarence area of Tasmania.
The Northern Territory trial focuses on health issues associated with a mobile population in remote locations, while the Tasmanian trial focuses on improving care to adults with diabetes by streamlining information exchange between health professionals, Lee said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.